Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
← catalyst calendarSponsored by Actinium Pharmaceuticals (industry) · ATNM — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
153actual
Sites
24
Countries
Canada, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2016 | not stated | When the study began enrolling |
| Primary completion | Jun 2022 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2026 | estimated | The whole study's end, after follow-up |
| First posted | 2016-01-27 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2023-07-19 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Acute Myeloid Leukemia
- Leukemia, Acute Myeloid
- Myeloid Leukemia, Acute
- Leukemia, Myeloid, Acute
- Acute Myelogenous Leukemia
- Leukemia, Acute Myelogenous
- Myelogenous Leukemia, Acute
- AML
- Bone Marrow Transplant
Interventions
- Drug: Iomab-B
- Drug: Conventional Care
- Procedure: HCT
Primary outcome
what the primary-completion date above is the date OFDurable Complete Remission (dCR)
measured 6 months from time of initial CR or CRp
Publications
- PMID 39298738 — linked by the registry
- PMID 35350938 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · ATNM's whole pipeline · Catalyst calendar · Every registered study · What changed